These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8398313)

  • 61. Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: an update.
    Choi NC; Carey RW
    Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):307-10. PubMed ID: 2546906
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Surgical management of small cell lung cancer: a case report.
    Graham B; Khansur T; Lambuth B; Balducci L
    J Miss State Med Assoc; 1988 Jun; 29(6):169-71. PubMed ID: 2840508
    [No Abstract]   [Full Text] [Related]  

  • 63. [Concurrent radiotherapy combined with carboplatin and etoposide in limited stage small cell lung cancer].
    Qiao TK; Zhou DA; Xin L; Shu L; Wu W
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):237-9. PubMed ID: 15144613
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
    J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Long-term survival following pneumonectomy, chemotherapy and radiotherapy in central small cell bronchial cancer].
    Lexer G; Weitensfelder W; Haiderer O; Wieser O
    Prax Klin Pneumol; 1988 Jul; 42(7):588-9. PubMed ID: 2847136
    [No Abstract]   [Full Text] [Related]  

  • 66. Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer.
    Garces YI; Okuno SH; Schild SE; Mandrekar SJ; Bot BM; Martens JM; Wender DB; Soori GS; Moore DF; Kozelsky TF; Jett JR
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):995-1001. PubMed ID: 17336213
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study.
    Aisner J; Goutsou M; Maurer LH; Cooper R; Chahinian P; Carey R; Skarin A; Slawson R; Perry MC; Green MR
    J Clin Oncol; 1992 Aug; 10(8):1230-6. PubMed ID: 1321892
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
    Glisson B; Komaki R; Lee JS; Shin DM; Fossella F; Murphy WK; Kurie J; Perez-Soler R; Schea R; Vadhan-Raj S
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):331-6. PubMed ID: 9457817
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.
    Daniels JR; Chak LY; Sikic BI; Lockbaum P; Kohler M; Carter SK; Reynolds R; Bohnen R; Gandara D; Yu J
    J Clin Oncol; 1984 Nov; 2(11):1192-9. PubMed ID: 6092554
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Radiotherapy and integrated treatment in carcinoma of the lung].
    Bottero G; Novella V; Spinoglio G
    Minerva Med; 1988 Apr; 79(4):275-9. PubMed ID: 2835711
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small-cell carcinoma of the lung.
    Murray N; Shah A; Brown E; Kostashuk E; Laukkanen E; Goldie J; Band P; Van den Hoek J; Murphy K; Sparling T
    Semin Oncol; 1986 Sep; 13(3 Suppl 3):24-30. PubMed ID: 3020695
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.
    Kubota K; Nishiwaki Y; Sugiura T; Noda K; Mori K; Kawahara M; Negoro S; Watanabe K; Imamura F; Tamura T; Saijo N
    Clin Cancer Res; 2005 Aug; 11(15):5534-8. PubMed ID: 16061870
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The effectiveness of 2 systems of chemoradiation treatment in inoperable small-cell lung cancer].
    Mikhina ZP; Bychkov MB; Motorina LI
    Vopr Onkol; 1989; 35(2):174-80. PubMed ID: 2538962
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial.
    Bunn PA; Lichter AS; Makuch RW; Cohen MH; Veach SR; Matthews MJ; Anderson AJ; Edison M; Glatstein E; Minna JD
    Ann Intern Med; 1987 May; 106(5):655-62. PubMed ID: 3032033
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Limited forms of treatment for small-cell cancers].
    Perol M
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S147-9. PubMed ID: 10088296
    [No Abstract]   [Full Text] [Related]  

  • 77. [Therapy of small-cell bronchial carcinoma].
    Bodemann HH; Arnold H; Wannenmacher M; Kraft A
    Dtsch Med Wochenschr; 1984 Jun; 109(23):913-5. PubMed ID: 6086263
    [No Abstract]   [Full Text] [Related]  

  • 78. [Advances in the diagnosis and treatment of lung cancer. II. Treatment of small cell cancer of the lung].
    Spiro SG
    Pneumonol Pol; 1990; 58(4-5):244-50. PubMed ID: 2168046
    [No Abstract]   [Full Text] [Related]  

  • 79. A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party.
    Bleehen NM; Girling DJ; Gregor A; Leonard RC; Machin D; McKenzie CG; Morgan DA; Smyth JF; Spittle MF; Stephens RJ
    Br J Cancer; 1991 Oct; 64(4):775-9. PubMed ID: 1654988
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
    Urtasun RC; Palmer M; Kinney B; Belch A; Hewitt J; Hanson J
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):337-42. PubMed ID: 9457818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.